Pere Ginés Gibert-rekin lankidetzan egindako argitalpenak (15)

2022

  1. Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure

    JHEP Reports, Vol. 4, Núm. 6

2021

  1. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis

    Gastroenterology, Vol. 160, Núm. 1, pp. 206-218.e13

2020

  1. Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes

    Journal of Hepatology, Vol. 72, Núm. 6, pp. 1132-1139

2019

  1. Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival

    Liver International, Vol. 39, Núm. 7, pp. 1246-1255

  2. Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study

    Hepatology, Vol. 70, Núm. 1, pp. 319-333

2018

  1. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial

    Journal of Hepatology, Vol. 69, Núm. 6, pp. 1250-1259

2017

  1. Adipocyte fatty-acid binding protein is overexpressed in cirrhosis and correlates with clinical outcomes

    Scientific Reports, Vol. 7, Núm. 1

  2. Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure

    Clinical Gastroenterology and Hepatology, Vol. 15, Núm. 3, pp. 438-445.e5

2016

  1. Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis

    Scientific Reports, Vol. 6

  2. Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis

    Journal of Hepatology, Vol. 65, Núm. 1, pp. 57-65

  3. Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis

    Journal of Hepatology, Vol. 65, Núm. 5, pp. 914-920

  4. The Management of Hyponatremia in Cirrhosis: Should it Be Pharmacologic?

    Current Hepatology Reports, Vol. 15, Núm. 1, pp. 53-59

  5. Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis

    PLoS ONE, Vol. 11, Núm. 6

2015

  1. Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis

    PLoS ONE, Vol. 10, Núm. 6

  2. Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: A case-control study

    Journal of Hepatology, Vol. 63, Núm. 3, pp. 593-600